SUPERNUS PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Supernus Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2012 to Q3 2024.
  • Supernus Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 30, 2024 was 55.2M shares, a 1.07% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 55.2M +586K +1.07% Oct 30, 2024 10-Q 2024-11-04
Q2 2024 55.1M +511K +0.94% Jul 30, 2024 10-Q 2024-08-06
Q1 2024 55M +498K +0.91% May 1, 2024 10-Q 2024-05-08
Q3 2023 54.6M +575K +1.06% Nov 1, 2023 10-Q 2023-11-08
Q2 2023 54.6M +1.1M +2.06% Aug 1, 2023 10-Q 2023-08-08
Q1 2023 54.5M +1.09M +2.04% May 3, 2023 10-Q 2023-05-09
Q3 2022 54.1M +877K +1.65% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 53.5M +349K +0.66% Aug 1, 2022 10-Q 2022-08-08
Q1 2022 53.4M +368K +0.69% Mar 30, 2022 10-K 2022-04-13
Q3 2021 53.2M +496K +0.94% Nov 1, 2021 10-Q 2021-11-05
Q2 2021 53.1M +482K +0.92% Aug 2, 2021 10-Q 2021-08-06
Q1 2021 53M +480K +0.91% Apr 30, 2021 10-Q 2021-05-07
Q3 2020 52.7M +222K +0.42% Oct 30, 2020 10-Q 2020-11-06
Q2 2020 52.7M +215K +0.41% Jul 31, 2020 10-Q 2020-08-17
Q1 2020 52.5M +154K +0.3% Apr 29, 2020 10-Q 2020-05-15
Q4 2019 52.5M +214K +0.41% Feb 13, 2020 10-K 2020-02-28
Q3 2019 52.5M +206K +0.39% Oct 31, 2019 10-Q 2019-11-08
Q2 2019 52.4M +235K +0.45% Aug 5, 2019 10-Q 2019-08-09
Q1 2019 52.4M +588K +1.14% May 1, 2019 10-Q 2019-05-10
Q4 2018 52.3M Feb 13, 2019 10-K 2019-03-01
Q3 2018 52.3M +995K +1.94% Nov 1, 2018 10-Q 2018-11-09
Q2 2018 52.2M +1.52M +2.99% Aug 3, 2018 10-Q 2018-08-09
Q1 2018 51.8M +1.63M +3.26% May 2, 2018 10-Q 2018-05-10
Q3 2017 51.3M Oct 31, 2017 10-Q 2017-11-09
Q2 2017 50.7M +1.19M +2.41% Jul 27, 2017 10-Q 2017-08-03
Q1 2017 50.2M +741K +1.5% Mar 9, 2017 10-K 2017-03-16
Q4 2016 50.1M Jan 17, 2017 10-Q/A 2017-01-23
Q2 2016 49.5M +1.06M +2.19% Jul 29, 2016 10-Q 2016-08-05
Q1 2016 49.4M +5.33M +12.1% Apr 29, 2016 10-Q 2016-05-10
Q3 2015 48.9M +5.99M +14% Oct 30, 2015 10-Q 2015-11-09
Q2 2015 48.4M +5.52M +12.9% Aug 3, 2015 10-Q 2015-08-07
Q1 2015 44.1M +2.04M +4.86% Mar 11, 2015 10-K 2015-03-12
Q3 2014 42.9M +9.09M +26.9% Oct 31, 2014 10-Q 2014-11-12
Q2 2014 42.9M +12M +38.7% Jul 31, 2014 10-Q 2014-08-12
Q1 2014 42M +11.2M +36.1% Mar 14, 2014 10-K 2014-03-21
Q3 2013 33.8M +9.31M +38% Nov 8, 2013 10-Q 2013-11-13
Q2 2013 30.9M +6.56M +26.9% Jul 31, 2013 10-Q 2013-08-14
Q1 2013 30.9M Feb 28, 2013 10-K 2013-03-15
Q3 2012 24.5M Oct 31, 2012 10-Q 2012-11-02
Q2 2012 24.4M May 31, 2012 10-Q 2012-06-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.